However, there are only five drugs approved for AD treatment, including four cholinesterase inhibitors (tacrine, rivastigmine, galantamine, and donepezil) and one glutaminergic N-methyl-D-aspartate (NMDA) receptor antagonist (memantine) [3]. The gene discussed is BCHE; the disease is Alzheimer disease.